Search Results - Xiangli Ren
- Showing 1 - 1 results of 1
-
1
Discovery of TK-642 as a highly potent, selective, orally bioavailable pyrazolopyrazine-based allosteric SHP2 inhibitor by Kai Tang, Shu Wang, Siqi Feng, Xinyu Yang, Yueyang Guo, Xiangli Ren, Linyue Bai, Bin Yu, Hong-Min Liu, Yihui Song
Published 2024Call Number: Loading…Connect to this object online.
Located: Loading…
Book